Journal of Pharmacy and Pharmaceutical Sciences

Papers
(The TQCC of Journal of Pharmacy and Pharmaceutical Sciences is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Evaluating the Effects of Agomelatine on Polysomnography Parameters in Patients with Obstructive Sleep Apnea.80
Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred59
Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines54
Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs47
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials42
Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition27
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments18
Effect of Concomitant Drug Use on the Onset and Exacerbation of Diabetes Mellitus in Everolimus-Treated Cancer17
Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Difference16
Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome16
Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System15
Applications of Exhaled Breath Condensate Analysis for Drug Monitoring and Bioequivalence Study of Inhaled Drugs15
Expanding the eligibility criteria for drugs in Canada’s time-limited health technology assessment and temporary drug access processes will further accelerate access to new medicines14
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy14
A Legislative/Legal History of Prescription Drug Advertising and Promotion Regulation14
The Lymphatic System: A Sometimes-Forgotten Compartment in Pharmaceutical Sciences13
From fasting to fat reshaping: exploring the molecular pathways of intermittent fasting-induced adipose tissue remodeling13
Real-world community hospital hyperglycemia management in noncritically ill, type 2 diabetic patients: a comparison between basal-bolus insulin and correctional insulin13
Effects of dual therapy with betamethasone and tetracycline in a NC/Nga mouse model of atopic dermatitis13
Biosimilars: A Comparative Study of Regulatory, Safety and Pharmacovigilance Monograph in the Developed and Developing Economies12
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy12
Remdesivir-induced conduction abnormalities: A molecular model-based explanation11
Community pharmacists as antimicrobial resistance stewards: a narrative review on their contributions and challenges in low- and middle-income countries11
Should Codeine Still be Considered a WHO Essential Medicine?11
Microneedles as an Alternative Strategy for Drug Delivery10
Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions9
Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective9
Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System9
The Effect of HIV/AIDS Infection on the Clinical Outcomes of COVID-19: A Meta-Analysis8
Metabolic flux in macrophages in obesity and type-2 diabetes8
Integration of real-world evidence from different data sources in health technology assessment7
Abstracts of poster presentations at the 2021 virtual annual of the Canadian Society for Pharmaceutical Sciences.7
0.76740598678589